National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 7/27/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Wallace Akerley, MD

None

Genentech, Inc.

None

None

3/5/2013

Hossein Borghaei, DO, MS

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.

Amgen Inc.;
Genentech, Inc.

None

None

7/2/2012

Andrew C. Chang, MD

None

None

None

None

5/15/2013

Richard T. Cheney, MD

None

OptumHealth

None

None

7/3/2012

Lucian R. Chirieac, MD

None

Boehringer Ingelheim GmbH;
Aposense;
Infinity;
Shook,Hardy&Bacon

None

None

5/1/2012

Thomas A. D'Amico, MD

None

Scanlan

None

None

2/28/2013

Todd L. Demmy, MD

None

None

None

None

10/12/2012

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix

None

None

2/28/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Covidien AG;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.

None

None

3/28/2012

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

City of Hope National Medical Center Board of Directors

6/18/2012

Stefan C. Grant, MD, JD

None

None

None

None

5/14/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Leora Horn, MD, MSc, FRCPC

None

None

None

None

8/16/2012

Miranda Hughes, PhD

None

None

None

None

4/10/2013

Thierry M. Jahan, MD

None

None

None

None

4/16/2013

Melissa Johnson, MD

Novartis Pharmaceuticals Corporation

None

None

None

7/5/2012

Ritsuko Komaki, MD

Pfizer Inc.

None

None

None

7/3/2012

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

10/9/2012

Mark G. Kris, MD

Boehringer Ingelheim GmbH;
Pfizer Inc.

Genentech, Inc.

None

None

3/4/2013

Lee M. Krug, MD

Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
CanBas

Genentech, Inc.;
MedImmune Inc.;
Morphotek Inc.

None

None

6/18/2012

Rudy P. Lackner, MD

None

None

None

None

3/2/2013

Inga T. Lennes, MD

None

None

None

None

6/18/2012

Billy W. Loo, MD, PhD

None

None

None

Siemens Medical Solutions Diagnostics;
Varian Medical Systems, Inc.

3/20/2013

Renato Martins, MD, MPH

None

Eli Lilly and Company;
Genentech, Inc.

None

None

4/8/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Gregory A. Otterson, MD

Abraxis Oncology;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.;
Pharmacyclics

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

1/23/2013

Jyoti D. Patel, MD

Eli Lilly and Company

Genentech, Inc.

None

None

3/26/2012

Mary C. Pinder-Schenck, MD

Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Pfizer Inc.

None

None

None

7/3/2012

Katherine M. Pisters, MD

None

None

None

None

4/10/2013

Karen Reckamp, MD, MS

Amgen Inc.;
GlaxoSmithKline;
Astelles;
Pfizer Inc.

Amgen Inc.

None

None

3/5/2013

Gregory J. Riely, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Abbott Moleclar;
Chugai;
Tragara

None

None

8/16/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Theresa A. Shapiro, MD, PhD

None

None

None

None

5/4/2012

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

7/5/2012

Kurt Tauer, MD

None

Eli Lilly and Company

None

None

7/5/2012

Douglas E. Wood, MD

None

None

None

None

5/11/2013

Stephen C. Yang, MD

None

None

None

None

6/18/2012